Evidence map›Paper›PMID 39001886›Full record

ArticleSocial psychiatry and psychiatric epidemiology2025

Impact of the COVID-19 pandemic on antidepressant consumption in the Central region of Portugal: interrupted time series.

Luciana G Negrão, Catarina Coelho, M Margarida Castel-Branco, Isabel V Figueiredo, Fernando Fernandez-Llimos

Abstract read
In one paragraph

Article in Social psychiatry and psychiatric epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Luciana G NegrãoPharmacology and Pharmaceutical Care Laboratory, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.ORCID http://orcid.org/0000-0002-7677-7065
Catarina CoelhoAdministração Regional de Saúde do Centro, IP (ARSC), Coimbra, Portugal.ORCID http://orcid.org/0000-0002-4600-0132
M Margarida Castel-BrancoPharmacology and Pharmaceutical Care Laboratory, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.ORCID http://orcid.org/0000-0002-6533-9932
Isabel V FigueiredoPharmacology and Pharmaceutical Care Laboratory, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.ORCID http://orcid.org/0000-0003-0127-4575
Fernando Fernandez-LlimosLaboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Jorge de Viterbo Ferreira 228, Porto, 4050-313, Portugal. fllimos@ff.up.pt.ORCID http://orcid.org/0000-0002-8529-9595

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the impact of the pandemic on the consumption of antidepressive agents in Central Portugal.

methodsTo estimate the causal effect of the pandemic an interrupted time series analysis was conducted. Data of antidepressant drugs monthly dispensed in community pharmacies between Jan-2010 and Dec-2021 were provided by the regional Health Administration. Anti-Parkinson dopaminergic agents and statins, theoretically not influenced by COVID-19 pandemics, were used as comparator series. The number of packages was converted into defined daily doses and presented as defined daily doses/1000 inhabitants/day. A Bayesian structural time-series model with CausalImpact on R/RStudio was used to predict the counterfactual. Analyses with different geographical granularity (9 sub-regions and 78 municipalities) were performed.

resultsWhen compared to counterfactual, regional consumption non-significantly increased after the pandemic declaration, with a relative effect of + 1.30% [95%CI -1.6%:4.2%]. When increasing the granularity, differences appeared between sub-region with significant increases in Baixo Mondego + 6.5% [1.4%:11.0%], Guarda + 4.4% [1.1%:7.7%] or Cova da Beira + 4.1% [0.17%:8.3%], but non-significant variation in the remaining 6 sub-regions. Differences are more obvious at municipality level, ranging from increases of + 37.00% [32.00%:42.00%] to decreases of -11.00% [-17.00%:-4.20%]. Relative impact positively correlated with percentage of elderly in the municipality (r = 0.301; p = 0.007), and negatively with population density (r=-0.243; p = 0.032). No other predicting variables were found.

conclusionAntidepressant consumption suffered very slight variations at regional level after the COVID-19 pandemic declaration. Analysis with higher granularity allowed identifying municipalities with higher impact (increase or decrease). The absence of clear association patterns suggests other causal hypotheses of the differences.

Indexed as

Antidepressive AgentsCOVID-19DepressionDrug UtilizationBayes TheoremFemaleHumansInterrupted Time Series AnalysisMalePandemicsPortugalSARS-CoV-2Antidepressive AgentsAntidepressive agentsCOVID-19Drug utilizationInterrupted time series analysisPharmacoepidemiology

Identifiers

PMID39001886
PMCPMC11870879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.